- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Female contraceptives have to be made with better safety says study
Female contraceptives are most commonly taken medications for birth control worlwide. The current unmet needs in the female contraceptives market are similar to those that were present ten years ago.
Currently, marketed contraceptives carry the risk of irregular bleeding patterns, weight gain, changes in mood, depression, migraine or headache, nausea, and acne. Side effects are one of the main reasons why patients may decide to discontinue contraceptive use, leading to unintended pregnancies reports the Global data in recent press release.
Key opinion leaders (KOLs) have expressed the opinion that some women are hesitant to take hormonal contraceptives because of the associated side effects. The unmet need for non-hormonal contraception is a significant concern for individuals who wish to avoid hormonal contraceptives for several reasons, such as side effects, personal preferences, or religious beliefs.
Access to contraceptive methods also remains a challenge in most countries. While contraceptives may be approved and launched, they may or may not be covered by insurance companies. If they are not covered, many patients are not able to afford them. Finally, awareness of different contraceptive methods has room to improve, since many patients and providers are unaware of many of the currently marketed forms of contraception and how to insert them if they require a device.
Compliance and adherence are other major unmet needs in the contraceptives market. Patients either do not remember to take their oral hormonal contraceptive every day or may discontinue their contraceptive altogether due to side effects.
Compliance difficulties are more common among oral contraceptive users partly because unintended pregnancy is a relatively infrequent consequence, and because more common manifestations such as spotting and bleeding may not be recognized as resulting from poor compliance. Educational interventions can help increase knowledge of available contraceptive methods, enabling individuals to make informed decisions and use contraception more effectively.
While there are methods of contraception that are long-lasting, such as hormonal intrauterine devices, which last anywhere from three to five years, these tend to cause side effects just like the daily oral contraceptives.
To address this unmet need, the development of user-friendly methods with fewer side effects that require less frequent administration is needed. Improving compliance and adherence is crucial for ensuring the effectiveness of contraceptive methods and preventing unintended pregnancies, and it requires a combination of healthcare provider support, education, and innovation in contraceptive options.
Reference: Female Contraceptives market needs therapeutics with better safety; Global data healthcare.
MSc. Neuroscience
Niveditha Subramani a MSc. Neuroscience (Faculty of Medicine) graduate from University of Madras, Chennai. Ambitious in Neuro research having worked in motor diseases and neuron apoptosis is interested in more of new upcoming research and their advancement in field of medicine. She has an engrossed skill towards writing and her roles at Medical dialogue include Sr. Content writer. Her news covers new discoveries and updates in field of medicine. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751